Maria J. Besso
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Enhancing mass spectrometry imaging accessibility using convolutional autoencoders for deriving hypoxia-associated peptides from tumors.
Journal: NPJ systems biology and applications
Published: January 12, 2024
Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 14, 2023
Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer.
Journal: Cancers
Published: November 30, 2023
Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways.
Journal: Frontiers in oncology
Published: October 18, 2023
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts.
Journal: Journal of translational medicine
Published: May 11, 2023
Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity.
Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity.
Journal: Molecular cancer research : MCR
Published: September 23, 2021
Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.
Journal: Frontiers in oncology
Published: November 12, 2019
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways.
Journal: Frontiers in oncology
Published: August 12, 2019
Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.
Journal: Oncology reports
Published: August 01, 2019
Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B.
Journal: Cancer & metabolism
Published: October 31, 2018
Last Updated: 09/26/2026